Literature DB >> 9700596

The effect of fasting, long-chain triglyceride load and carnitine load on plasma long-chain acylcarnitine levels in mitochondrial very long-chain acyl-CoA dehydrogenase deficiency.

C G Costa1, L Dorland, I T de Almeida, C Jakobs, M Duran, B T Poll-The.   

Abstract

We studied a 10-year-old patient with very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency who was originally (mis)diagnosed as having systemic carnitine deficiency. He was subjected to a fasting test, a long-chain triglyceride (LCT) loading test (1.5 g/kg) and an intravenous carnitine clearance test (0.25 mumol/kg per min). Plasma acylcarnitines were analysed using a quantitative GC-CI-MS method. During fasting, all long-chain acylcarnitines with a chain length of C14 and higher (especially C14:1) increased dramatically. Total plasma long-chain acylcarnitine reached a concentration of 28.6 mumol/L. LCT loading resulted in a moderate increase, mainly of the C18 esters. The carnitine infusion, which led to a supranormal plasma free carnitine concentration, gave only a slight but generalized rise of long-chain acylcarnitines. Although only one patient could be tested, the results suggest that the accumulation of potentially toxic long-chain acylcarnitines in VLCAD deficiency is provoked by fasting, LCT loading and carnitine supplementation. Therapy should be adjusted accordingly.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9700596     DOI: 10.1023/a:1005354624735

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  12 in total

1.  Quantitative analysis of plasma acylcarnitines using gas chromatography chemical ionization mass fragmentography.

Authors:  C G Costa; E A Struys; A Bootsma; H J ten Brink; L Dorland; I Tavares de Almeida; M Duran; C Jakobs
Journal:  J Lipid Res       Date:  1997-01       Impact factor: 5.922

Review 2.  Acylcarnitines in intermediary metabolism.

Authors:  A C Sewell; H J Böhles
Journal:  Eur J Pediatr       Date:  1995-11       Impact factor: 3.183

Review 3.  The changing face of disorders of fatty acid oxidation.

Authors:  J Vockley
Journal:  Mayo Clin Proc       Date:  1994-03       Impact factor: 7.616

Review 4.  Carnitine esters in metabolic disease.

Authors:  H Böhles; A Evangeliou; K Bervoets; I Eckert; A Sewell
Journal:  Eur J Pediatr       Date:  1994       Impact factor: 3.183

5.  Systemic carnitine deficiency: benefit of oral carnitine supplements vs. persisting biochemical abnormalities.

Authors:  M Duran; J B de Klerk; S K Wadman; H R Scholte; R P Beekman; F G Jennekens
Journal:  Eur J Pediatr       Date:  1984-08       Impact factor: 3.183

6.  Primary systemic carnitine deficiency. II. Renal handling of carnitine.

Authors:  A G Engel; C J Rebouche; D M Wilson; A M Glasgow; C A Romshe; R P Cruse
Journal:  Neurology       Date:  1981-07       Impact factor: 9.910

7.  Reduction pathway of cis-5 unsaturated fatty acids in intact rat-liver and rat-heart mitochondria: assessment with stable-isotype-labelled substrates.

Authors:  K Y Tserng; S J Jin; L S Chen
Journal:  Biochem J       Date:  1996-01-15       Impact factor: 3.857

8.  Very long-chain acyl coenzyme A dehydrogenase deficiency presenting with exercise-induced myoglobinuria.

Authors:  I Ogilvie; M Pourfarzam; S Jackson; C Stockdale; K Bartlett; D M Turnbull
Journal:  Neurology       Date:  1994-03       Impact factor: 9.910

9.  Intravenous L-carnitine and acetyl-L-carnitine in medium-chain acyl-coenzyme A dehydrogenase deficiency and isovaleric acidemia.

Authors:  J L Van Hove; S G Kahler; D S Millington; D S Roe; D H Chace; S J Heales; C R Roe
Journal:  Pediatr Res       Date:  1994-01       Impact factor: 3.756

10.  Inborn errors of metabolism diagnosed in sudden death cases by acylcarnitine analysis of postmortem bile.

Authors:  M S Rashed; P T Ozand; M J Bennett; J J Barnard; D R Govindaraju; P Rinaldo
Journal:  Clin Chem       Date:  1995-08       Impact factor: 8.327

View more
  7 in total

1.  Acylcarnitines are anticoagulants that inhibit factor Xa and are reduced in venous thrombosis, based on metabolomics data.

Authors:  Hiroshi Deguchi; Yajnavalka Banerjee; Sunia Trauger; Gary Siuzdak; Ewa Kalisiak; José A Fernández; Linh Hoang; Minerva Tran; Subramanian Yegneswaran; Darlene J Elias; John H Griffin
Journal:  Blood       Date:  2015-07-14       Impact factor: 22.113

2.  Clear correlation of genotype with disease phenotype in very-long-chain acyl-CoA dehydrogenase deficiency.

Authors:  B S Andresen; S Olpin; B J Poorthuis; H R Scholte; C Vianey-Saban; R Wanders; L Ijlst; A Morris; M Pourfarzam; K Bartlett; E R Baumgartner; J B deKlerk; L D Schroeder; T J Corydon; H Lund; V Winter; P Bross; L Bolund; N Gregersen
Journal:  Am J Hum Genet       Date:  1999-02       Impact factor: 11.025

3.  Outcomes and genotype-phenotype correlations in 52 individuals with VLCAD deficiency diagnosed by NBS and enrolled in the IBEM-IS database.

Authors:  Loren D M Pena; Sandra C van Calcar; Joyanna Hansen; Mathew J Edick; Cate Walsh Vockley; Nancy Leslie; Cynthia Cameron; Al-Walid Mohsen; Susan A Berry; Georgianne L Arnold; Jerry Vockley
Journal:  Mol Genet Metab       Date:  2016-05-13       Impact factor: 4.797

4.  Elevations of C14:1 and C14:2 Plasma Acylcarnitines in Fasted Children: A Diagnostic Dilemma.

Authors:  Lindsay C Burrage; Marcus J Miller; Lee-Jun Wong; Adam D Kennedy; V Reid Sutton; Qin Sun; Sarah H Elsea; Brett H Graham
Journal:  J Pediatr       Date:  2015-11-18       Impact factor: 4.406

5.  Minor Plasma Lipids Modulate Clotting Factor Activities and May Affect Thrombosis Risk.

Authors:  Hiroshi Deguchi; Darlene J Elias; John H Griffin
Journal:  Res Pract Thromb Haemost       Date:  2017-06-20

6.  Mitochondrial energetics is impaired in very long-chain acyl-CoA dehydrogenase deficiency and can be rescued by treatment with mitochondria-targeted electron scavengers.

Authors:  Bianca Seminotti; Guilhian Leipnitz; Anuradha Karunanidhi; Catherine Kochersperger; Vera Y Roginskaya; Shrabani Basu; Yudong Wang; Peter Wipf; Bennett Van Houten; Al-Walid Mohsen; Jerry Vockley
Journal:  Hum Mol Genet       Date:  2019-03-15       Impact factor: 6.150

Review 7.  Recent Advances in the Pathophysiology of Fatty Acid Oxidation Defects: Secondary Alterations of Bioenergetics and Mitochondrial Calcium Homeostasis Caused by the Accumulating Fatty Acids.

Authors:  Alexandre Umpierrez Amaral; Moacir Wajner
Journal:  Front Genet       Date:  2020-11-27       Impact factor: 4.599

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.